Your browser doesn't support javascript.
loading
Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome.
Lynch, Stephen M; DeVicente, Javier; Hermann, Johannes C; Jaime-Figueroa, Saul; Jin, Sue; Kuglstatter, Andreas; Li, Hongju; Lovey, Allen; Menke, John; Niu, Linghao; Patel, Vaishali; Roy, Douglas; Soth, Michael; Steiner, Sandra; Tivitmahaisoon, Parcharee; Vu, Minh Diem; Yee, Calvin.
Afiliación
  • Lynch SM; Discovery Chemistry, Hoffmann-La Roche, pRED, Pharma Research & Early Development, 340 Kingsland Street, Nutley, NJ 07110, USA. stephen.lynch@roche.com
Bioorg Med Chem Lett ; 23(9): 2793-800, 2013 May 01.
Article en En | MEDLINE | ID: mdl-23540648
Using a structure based design approach we have identified a series of indazole substituted pyrrolopyrazines, which are potent inhibitors of JAK3. Intramolecular electronic repulsion was used as a strategy to induce a strong conformational bias within the ligand. Compounds bearing this conformation participated in a favorable hydrophobic interaction with a cysteine residue in the JAK3 binding pocket, which imparted high selectivity versus the kinome and improved selectivity within the JAK family.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Inhibidores de Proteínas Quinasas / Janus Quinasa 3 Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Inhibidores de Proteínas Quinasas / Janus Quinasa 3 Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos